JP Morgan Downgrades Amrize to Neutral, Lowers Price Target to $52

Benzinga Newsdesk www.benzinga.com Negative 90.2%

Neg 90.2% Neu 0% Pos 0%

JP Morgan analyst Adrian Huerta downgrades Amrize (NYSE:AMRZ) from Overweight to Neutral and lowers the price target from $57 to $52.